94 related articles for article (PubMed ID: 8593350)
1. [Determination of antibodies to HLA class I antigens by an immunoenzyme method].
Borozdenkova SD; Baryshnikov AIu; Palkina TN; Baranova FS
Biull Eksp Biol Med; 1995 Sep; 120(9):315-7. PubMed ID: 8593350
[No Abstract] [Full Text] [Related]
2. Anti-HLA class I antibody inhibits Staphylococcus enterotoxin A (SEA)-induced proliferation of human PBMC.
Baskar P; Hildreth JE; Chrest FJ; Nagel JE; Adler WH
Cell Immunol; 1996 Aug; 172(1):135-8. PubMed ID: 8806816
[TBL] [Abstract][Full Text] [Related]
3. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens.
Duquesnoy RJ; Marrari M
Tissue Antigens; 2009 Aug; 74(2):117-33. PubMed ID: 19497041
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte antigen class I epitopes: update to 103 total epitopes, including the C locus.
El-Awar NR; Akaza T; Terasaki PI; Nguyen A
Transplantation; 2007 Aug; 84(4):532-40. PubMed ID: 17713439
[TBL] [Abstract][Full Text] [Related]
5. Production and applications of new monoclonal antibodies against human lymphocyte antigen-A and -B antigens.
Harpprecht J; Westphal E; Müller-Ruchholtz W
Diagn Clin Immunol; 1988; 5(6):388-92. PubMed ID: 3219787
[TBL] [Abstract][Full Text] [Related]
6. [Influence of HLA class I molecules expression on tumor cell resistance to NK lysis and the IFN-gamma regulatory effect].
Zhang C; Tian Z; Hou G
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):369-72. PubMed ID: 11810763
[TBL] [Abstract][Full Text] [Related]
7. A possible role for the production of multiple HLA antibodies in fatal platelet transfusion refractoriness after peripheral blood progenitor cell transplantation from the mother in a patient with relapsed leukemia.
Nakazawa Y; Saito S; Hasegawa Y; Yanagisawa R; Sakashita K; Kamijo T; Miyazaki T; Sato S; Ikeda H; Ikebuchi K; Koike K
Transfusion; 2007 Feb; 47(2):326-34. PubMed ID: 17302780
[TBL] [Abstract][Full Text] [Related]
8. Relationship between soluble HLA-G and HLA-A,-B,-C serum levels, and interferon-gamma production after sublingual immunotherapy in patients with allergic rhinitis.
Ciprandi G; Continia P; Fenoglio D; Sormani MP; Negrini S; Puppo F; Indiveri F
Hum Immunol; 2008 Jul; 69(7):409-13. PubMed ID: 18573288
[TBL] [Abstract][Full Text] [Related]
9. Rapid assessment of the antigenic integrity of tetrameric HLA complexes by human monoclonal HLA antibodies.
Eijsink C; Kester MG; Franke ME; Franken KL; Heemskerk MH; Claas FH; Mulder A
J Immunol Methods; 2006 Aug; 315(1-2):153-61. PubMed ID: 16973172
[TBL] [Abstract][Full Text] [Related]
10. Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma.
Raffaghello L; Nozza P; Morandi F; Camoriano M; Wang X; Garrè ML; Cama A; Basso G; Ferrone S; Gambini C; Pistoia V
Cancer Res; 2007 Jun; 67(11):5471-8. PubMed ID: 17545629
[TBL] [Abstract][Full Text] [Related]
11. Computer algorithm that predicts both acceptable and unacceptable private and public HLA class I antigens in highly sensitized patients.
Thompson JS; Bryne JE; Hempel HO; Oldfather JW; Green WF; Crowe DO; Sanfilippo F; MacQueen JM; McCalmon RN; Tardiff GN
Transplant Proc; 1993 Feb; 25(1 Pt 1):251-4. PubMed ID: 8438290
[No Abstract] [Full Text] [Related]
12. [Interaction between natural killer (NK) cells and the major histocompatibility system].
Bishara A; Brautbar C; Nagler A
Harefuah; 1996 Mar; 130(5):322-6. PubMed ID: 8707177
[No Abstract] [Full Text] [Related]
13. Outcome of kidney transplantation in highly sensitized patients in Scandiatransplant.
Lamm LU; Madsen M; Fjeldborg D
Transplant Proc; 1987 Feb; 19(1 Pt 1):729-30. PubMed ID: 3274855
[No Abstract] [Full Text] [Related]
14. Re-exposure to mismatched HLA class I is a significant risk factor for graft loss: multivariable analysis of 259 kidney retransplants.
House AA; Chang PC; Luke PP; Leckie SH; Howson WT; Ball EJ; Tan AK; Rehman F; Muirhead N; Hollomby DJ; McAlister VC; Hodsman AB; Jevnikar AM
Transplantation; 2007 Sep; 84(6):722-8. PubMed ID: 17893605
[TBL] [Abstract][Full Text] [Related]
15. Studies on the human leukocyte antigen class I antigens in Japanese patients with macroscopically diagnosed endometriosis.
Ishii K; Takakuwa K; Adachi H; Higashino M; Hataya I; Tanaka K
Gynecol Obstet Invest; 2002; 54(3):150-3. PubMed ID: 12571436
[TBL] [Abstract][Full Text] [Related]
16. Detection and specification of noncomplement binding anti-HLA alloantibodies.
Arnold ML; Zacher T; Dechant M; Kalden JR; Doxiadis II; Spriewald BM
Hum Immunol; 2004 Nov; 65(11):1288-96. PubMed ID: 15556679
[TBL] [Abstract][Full Text] [Related]
17. HLA class I epitopes: A and B loci.
El-Awar N; Cook D; Terasaki PI
Clin Transpl; 2006; ():79-94. PubMed ID: 18365370
[TBL] [Abstract][Full Text] [Related]
18. HLA-B51 transgenic mice as recipients for production of polymorphic HLA-A, B-specific antibodies.
Karaki S; Kariyone A; Kato N; Kano K; Iwakura Y; Takiguchi M
Immunogenetics; 1993; 37(2):139-42. PubMed ID: 8423053
[No Abstract] [Full Text] [Related]
19. Therapeutic preparations of IVIg contain naturally occurring anti-HLA-E antibodies that react with HLA-Ia (HLA-A/-B/-Cw) alleles.
Ravindranath MH; Terasaki PI; Pham T; Jucaud V; Kawakita S
Blood; 2013 Mar; 121(11):2013-28. PubMed ID: 23305735
[TBL] [Abstract][Full Text] [Related]
20. The epitope recognized by pan-HLA class I-reactive monoclonal antibody W6/32 and its relationship to unusual stability of the HLA-B27/beta2-microglobulin complex.
Tran TM; Ivanyi P; Hilgert I; Brdicka T; Pla M; Breur B; Flieger M; Ivasková E; Horejsí V
Immunogenetics; 2001 Aug; 53(6):440-6. PubMed ID: 11685454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
